Janumet Tablet, Film Coated
Product Images NDC 0006-0577

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Janumet (NDC 0006-0577). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sitagliptin Chemical Structure (Janumet 01)

Chemical structure of Sitagliptin, one of the active ingredients in JANUMET (Sitagliptin and Metformin Hydrochloride). The structure includes a trifluoromethyl group, a piperazine ring, and phosphate and water molecules.*

FDA Label Image

Metformin Hydrochloride Chemical Structure (Janumet 02)

Chemical structure of sitagliptin and metformin hydrochloride, the active ingredients in JANUMET tablets.*

FDA Label Image

Figure 1 (Janumet 03)

A line graph showing the least squares (LS) mean change from baseline over 24 weeks comparing the effects of placebo, Sitagliptin 100 mg once daily, Metformin 500 mg twice daily, Metformin 1000 mg twice daily, and combinations of Sitagliptin 50 mg twice daily with Metformin 500 mg or 1000 mg twice daily. The graph illustrates treatment differences over time.*

FDA Label Image

Figure 2 (Janumet 04)

A line graph comparing the least squares mean change from baseline over 52 weeks between Sitagliptin 100 mg and Glipizide. The vertical axis represents the change from baseline, ranging from 0.0 to -1.5, while the horizontal axis shows the time in weeks from 0 to 52. Both Sitagliptin 100 mg and Glipizide show an initial decrease in values, reaching a low around week 30, followed by a slight increase towards week 52.*

FDA Label Image

Principal Display Panel (50 mg/500 mg Tablet Bottle Label)

Janumet 50 mg/500 mg film-coated tablets label for sitagliptin and metformin HCl oral tablets. The label includes dosage strength, medication guide instruction, and NDC 0006-0575-61. It shows an image of an oblong tablet with "575" embossed. Manufactured by Merck Sharp & Dohme LLC.*

FDA Label Image

Principal Display Panel (50 mg/1,000 mg Tablet Bottle Label)

JANUMET 50 mg/1,000 mg film-coated tablets label showing the brand name and generic names (sitagliptin and metformin HCl). The label includes storage instructions, barcodes, a red and white color scheme, the Merck Sharp & Dohme LLC labeler, and an image of an oval orange tablet imprinted with '577'. The package contains 60 tablets and indicates prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.